Ealixir, Inc.
EAXR · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $57 | $83 | $78 | $90 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $57 | $83 | $78 | $91 |
| Revenue | $1 | $1 | – | $0 |
| % Growth | -35% | – | – | – |
| Gross Profit | $1 | $1 | – | $0 |
| % Margin | 93.7% | 91.8% | – | 35.4% |
| EBITDA | $0 | $0 | – | -$1 |
| % Margin | 8% | 5.8% | – | -254.3% |
| Net Income | $0 | $0 | – | -$1 |
| % Margin | 6.4% | 0% | – | -237.1% |
| EPS Diluted | 0 | 0 | – | -0.011 |
| % Growth | -100% | – | – | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |